Related Experiment Video
Updated: Jul 31, 2026
11:36
Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Published on: May 29, 2020
Liver disease associated with alpha1-antitrypsin deficiency
1Division of Gastroenterology and Hepatology, Oregon Health Sciences University, Portland Veterans Affairs Medical Center, Portland, Oregon 97207, USA.
Clinics in Liver Disease
|November 25, 2004
Summary
Alpha-1 antitrypsin deficiency (AATD) is a common genetic condition causing liver disease in children and adults. Research into cellular events offers hope for future AATD therapies.
Area of Science:
- Genetics
- Hepatology
- Pulmonology
Background:
- Alpha-1 antitrypsin deficiency (AATD) is the most frequent metabolic liver disease in pediatric patients requiring liver transplantation.
- In adults, AATD is linked to severe conditions including liver cirrhosis, hepatocellular carcinoma, and pulmonary emphysema.
- Clinical manifestation of AATD varies, with only a subset of deficient individuals developing disease symptoms.
Purpose of the Study:
- To summarize the current understanding of Alpha-1 antitrypsin deficiency (AATD).
- To highlight the basis for potential therapeutic interventions in AATD.
- To underscore the significance of AATD in both pediatric and adult medicine.
Main Methods:
- Review of existing literature on Alpha-1 antitrypsin deficiency.
- Analysis of cellular and physiological events associated with AATD.
- Synthesis of findings to identify therapeutic targets.
Main Results:
- AATD is a primary indication for liver transplantation in children.
- AATD is associated with significant morbidity in adults, including liver and lung disease.
- Understanding of AATD pathophysiology has advanced, paving the way for new treatments.
Conclusions:
- AATD represents a significant health concern with diverse clinical outcomes.
- Further research into the cellular mechanisms of AATD is crucial for therapeutic development.
- Targeted interventions hold promise for managing AATD-related diseases.
Related Concept Videos
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:24Chronic Pancreatitis I: Introduction
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:25Chronic Pancreatitis I: Introduction
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...